Letters Sentinel node biopsy for melanoma

Call for a balanced view on sentinel node biopsy for melanoma

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f648 (Published 06 February 2013) Cite this as: BMJ 2013;346:f648
  1. Jenny L C Geh, consultant plastic surgeon1,
  2. Ciaran Healy, consultant plastic surgeon1,
  3. Katie Lacy, consultant dermatologist1,
  4. Mary Wain, consultant dermatologist1,
  5. Natalie Attard, consultant dermatologist1,
  6. Eduardo Calonje, consultant dermatopathologist,
  7. Mark Harries, consultant oncologist1,
  8. Michael O’Doherty, consultant in nuclear medicine1,
  9. Danuta Orlowska, clinical psychologist for skin cancer service1
  1. 1Guy’s and St Thomas’ NHS Foundation Trust, St Thomas’ Hospital, London SE1 7EH, UK
  1. jenny.geh{at}gstt.nhs.uk

The title of Torjesen’s article could be misleading.1 Sentinel node biopsy (SNB) is a staging tool used to provide patients with the best available information,2 and is a well established prognostic test.

Our research shows that patients want information on prognosis.3 Lymph node status is the most meaningful prognostic indicator and SNB the most sensitive …

Sign in

Subscribe